Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mir Rooh Ullah Jan, Haleema Saeed, Muhammad Abubakar & Rabia Muhammad Wali. (2020) Response rates, long term outcomes and toxicity profile of gemcitabine and vinorelbine based outpatient chemotherapy regimen in primary progressive and relapsed childhood Hodgkin lymphoma. Leukemia & Lymphoma 61:14, pages 3369-3377.
Read now
Read now
Constantin A Dasanu. (2008) Gemcitabine: vascular toxicity and prothrombotic potential. Expert Opinion on Drug Safety 7:6, pages 703-716.
Read now
Read now
Articles from other publishers (22)
Manasa Anipindi, Justyna Kacarow & Daniel Bitetto. (2023) Systemic Capillary Leak Syndrome (SCLS) Presentation in Patients Receiving Anti-cancer Treatments. Cureus.
Crossref
Crossref
Hassan Izzedine, Alexis Mathian, Zahir Amoura, Jia H. Ng & Kenar D. Jhaveri. (2022) Anticancer Drugs-induced Capillary Leak Syndrome. Kidney International Reports.
Crossref
Crossref
Nicola J. Nasser, Miguel Gorenberg & Abed Agbarya. (2020) First line Immunotherapy for Non-Small Cell Lung Cancer. Pharmaceuticals 13:11, pages 373.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
521
523
.
Wei Wu, Qing Xia, Rui-Jie Luo, Zi-Qi Lin & Ping Xue. (2015) In vitro Study of the Antagonistic Effect of Low-dose Liquiritigenin on Gemcitabine-induced Capillary Leak Syndrome in Pancreatic Adenocarcinoma via Inhibiting ROS-Mediated Signalling Pathways. Asian Pacific Journal of Cancer Prevention 16:10, pages 4369-4376.
Crossref
Crossref
L. Duron, F. Delestre, Z. Amoura & L. Arnaud. (2015) Syndrome de fuite capillaire idiopathique et formes secondaires : une revue systématique de la littérature. La Revue de Médecine Interne 36:6, pages 386-394.
Crossref
Crossref
Andrea Casadei Gardini, Michele Aquilina, Devil Oboldi, Alessandro Lucchesi, Silvia Carloni, Elena Tenti, Marco Angelo Burgio, Dino Amadori & Giovanni Luca Frassineti. (2013) Separate episodes of capillary leak syndrome and pulmonary hypertension after adjuvant gemcitabine and three years later after nab-paclitaxel for metastatic disease. BMC Cancer 13:1.
Crossref
Crossref
Etienne LemarieLaurent VecellioJose HureauxCaroline PrunierChantal ValatDaniel GrimbertMichele Boidron-CelleBruno GiraudeauAlain le PapeEric PichonPatrice DiotAbder el HoufiaFrederic Gagnadoux. (2011) Aerosolized Gemcitabine in Patients with Carcinoma of the Lung: Feasibility and Safety Study. Journal of Aerosol Medicine and Pulmonary Drug Delivery 24:6, pages 261-270.
Crossref
Crossref
. 2010. Meyler's Side Effects of Drugs in Cancer and Immunology. Meyler's Side Effects of Drugs in Cancer and Immunology
1
229
.
K. Jidar, S. Ingen-Housz-Oro, M. Beylot-Barry, C. Paul, D. Chaoui, M. Sigal-Grinberg, P. Morel, L. Dubertret & H. Bachelez. (2009) Gemcitabine treatment in cutaneous T-cell lymphoma: a multicentre study of 23 cases. British Journal of Dermatology 161:3, pages 660-663.
Crossref
Crossref
Isao Kurosaki, Yasuyuki Kawachi, Koei Nihei, Yoshiaki Tsuchiya, Takashi Aono, Naoyuki Yokoyama, Takeaki Shimizu & Katsuyoshi Hatakeyama. (2009) Liver Perfusion Chemotherapy With 5-Fluorouracil Followed by Systemic Gemcitabine Administration for Resected Pancreatic Cancer. Pancreas 38:2, pages 161-167.
Crossref
Crossref
. 2009. MeylerâÂÂs Side Effects of Cardiovascular Drugs. MeylerâÂÂs Side Effects of Cardiovascular Drugs
557
820
.
Edith Huland, Hans Heinzer & Hartwig Huland. 2008. Renal Cell Cancer. Renal Cell Cancer
427
448
.
Laetitia Dahan, Emmanuelle Ressiot, Agnès Cournede, Pauline Ries, Muriel Duluc, Arthur Laquiere, René Laugier, Diane Braguer & Jean-François Seitz. (2007) L’anasarque : une complication du traitement par la gemcitabine chez deux malades porteurs d’un cancer du pancréas. Gastroentérologie Clinique et Biologique 31:12, pages 1143-1145.
Crossref
Crossref
Roxana G. Baluna. 2007. Cytokines in Human Health. Cytokines in Human Health
205
231
.
Steven M. Belknap, Timothy M. Kuzel, Paul R. Yarnold, Nicholas Slimack, E. Allison Lyons, Dennis W. Raisch & Charles L. Bennett. (2006) Clinical features and correlates of gemcitabine‐associated lung injury. Cancer 106:9, pages 2051-2057.
Crossref
Crossref
Sima JehaPaul S. GaynonBassem I. RazzoukJanet FranklinRichard KadotaViolet ShenLori Luchtman-JonesMichael RyttingLisa R. BomgaarsSusan RheingoldKim RitcheyEdythe AlbanoRobert J. ArceciStewart GoldmanTimothy GriffinArnold AltmanBruce GordonLaurel SteinherzSteven WeitmanPeter Steinherz. (2006) Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 24:12, pages 1917-1923.
Crossref
Crossref
C. Isnard-Bagnis, B. Moulin, V. Launay-Vacher, H. Izzedine, I. Tostivint & G. Deray. (2006) Toxicité rénale des anticancéreux. EMC - Néphrologie 1:1, pages 1-10.
Crossref
Crossref
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions
1484
1486
.
Corinne Isnard-Bagnis, Bruno Moulin, Vincent Launay-Vacher, Hassan Izzedine, Isabelle Tostivint & Gilbert Deray. (2005) Toxicit? r?nale des anticanc?reux. N?phrologie & Th?rapeutique 1:2, pages 101-114.
Crossref
Crossref
S. Biswas, S. Nik & P.G. Corrie. (2004) Severe gemcitabine-induced capillary-leak Syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease. Clinical Oncology 16:8, pages 577-579.
Crossref
Crossref
Edith Huland & Hans Heinzer. (2004) Renal cell carcinoma - innovative medical treatments. Current Opinion in Urology 14:4, pages 239-244.
Crossref
Crossref